載入...
The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy Diagnostics
The evolution of chemistries and instrument platforms for next‐generation sequencing has led to sequencing of genomic variants in both tumor biopsies as well as in circulating tumor cells (CTCs) and cell‐free DNA liquid biopsies. The transition of these analytical platforms into clinical ones has le...
Na minha lista:
| 發表在: | Clin Transl Sci |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6742934/ https://ncbi.nlm.nih.gov/pubmed/31162800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12657 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|